Videos

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses some common problems that arise during a disaster.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about mistakes that some pharmacists make that can disrupt patient loyalty.

Kalin M. Clifford, PharmD, BCPS, discusses when treatment with memantine or cholinesterase should be stopped in patients with dementia.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, discusses challenges pharmacists need to overcome as health care models shift to pay-for-performance reimbursement models.

This weekly video program highlights the latest in pharmacy news, product news, and more.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about the most common challenges patients face when trying to set up travel immunizations.

National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the development of medical marijuana within the specialty space.

Carlos Aquino, founder and president of PharmaDiversion LLC, talks about his experience working undercover for the Philadelphia Drug Enforcement Administration task force.

Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses the alignment between specialty pharmacies and ACOs.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about the benefits of having a travel section in a pharmacy.

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the rewards and challenges of treating geriatric patients.

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the drugs that should be used cautiously when treating geriatric patients.

Judy Beizer, PharmD, CBP, FASCP, AGSF, discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Kalin M. Clifford, PharmD, BCPS, discusses the pharmacist's role in managing conditions such as dementia or atrial fibrillation in the geriatric population.

Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.

Mark Parkinson, CEO of the American Health Care Association, discusses challenges and opportunities that consultant pharmacists might encounter in the post-acute care industry.

Mark Parkinson, CEO of the American Health Care Association, discusses potential changes that may occur in the post-acute care industry.

Mark Parkinson, CEO of the American Health Care Association, discusses how the roles and responsibilities of pharmacists might evolve in response to recent changes within the past-acute care industry.

Mark Parkinson, CEO of the American Health Care Association, discusses how recent changes within the post-acute care industry might benefit or hinder pharmacists.

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses how consultant pharmacists and provider organizations can help one another to achieve their respective objectives.

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the ways in which provider organizations have attempted to manage risk.

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses how the objectives of consultant pharmacists differ from those of provider organizations.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the rewards and challenges of treating geriatric patients.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the drugs that should be used cautiously when treating geriatric patients.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the recent changes made to the American Geriatrics Society Beers Criteria.

Elias Cachine, PharmD, discusses how pharmacists can prevent inappropriate antimicrobial use.

Elias Cachine, PharmD, discusses the factors that can potentially contribute to antimicrobial overuse in geriatric patients.

Elias Cachine, PharmD, discusses the potential complications that can arise as a result of antibiotic overuse in geriatric patients.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the pharmacist's role in treating patients who are experiencing renal impairment.